CHIAPPALUPI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.679
EU - Europa 1.300
AS - Asia 1.211
SA - Sud America 280
AF - Africa 32
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.515
Nazione #
US - Stati Uniti d'America 1.615
SG - Singapore 515
IT - Italia 463
BR - Brasile 239
IE - Irlanda 205
CN - Cina 195
HK - Hong Kong 176
RU - Federazione Russa 112
DE - Germania 104
KR - Corea 86
VN - Vietnam 62
SE - Svezia 60
GB - Regno Unito 47
FI - Finlandia 46
NL - Olanda 43
RO - Romania 37
CA - Canada 34
FR - Francia 33
AT - Austria 31
UA - Ucraina 30
IN - India 29
JP - Giappone 23
TR - Turchia 23
MX - Messico 20
PH - Filippine 18
PL - Polonia 18
ES - Italia 16
BE - Belgio 14
ZA - Sudafrica 14
AR - Argentina 13
BD - Bangladesh 12
IQ - Iraq 11
CH - Svizzera 9
CO - Colombia 8
EC - Ecuador 7
PK - Pakistan 7
AU - Australia 6
IR - Iran 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
LB - Libano 5
MD - Moldavia 5
TW - Taiwan 5
CZ - Repubblica Ceca 4
ID - Indonesia 4
IL - Israele 4
LT - Lituania 4
PY - Paraguay 4
TN - Tunisia 4
UZ - Uzbekistan 4
AL - Albania 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GR - Grecia 3
HU - Ungheria 3
KH - Cambogia 3
KZ - Kazakistan 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PA - Panama 3
EU - Europa 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
NP - Nepal 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
BY - Bielorussia 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
IS - Islanda 1
KE - Kenya 1
LV - Lettonia 1
MW - Malawi 1
NO - Norvegia 1
PE - Perù 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 4.515
Città #
Singapore 379
Chandler 253
Dublin 201
Perugia 193
Hong Kong 167
Ashburn 108
San Mateo 89
Santa Clara 77
Boardman 76
Moscow 47
Beijing 45
Dearborn 44
Redmond 44
Medford 41
Altamura 40
Ann Arbor 40
Munich 40
Princeton 40
Los Angeles 39
Wilmington 38
Seoul 36
Bucharest 34
The Dalles 33
New York 28
Bologna 27
Vienna 27
Andover 26
São Paulo 24
Lawrence 23
Ho Chi Minh City 21
Falls Church 19
Seongnam-si 19
Tokyo 17
Piscataway 15
Brussels 14
Montreal 14
Falkenstein 13
Amsterdam 12
Norwalk 12
Cebu City 11
Hanoi 11
Helsinki 11
Johannesburg 11
Nuremberg 11
Phoenix 11
Brooklyn 10
Saint Petersburg 10
Warsaw 10
London 9
Milan 9
Parma 9
Redwood City 9
Rome 9
Boston 8
Brasília 8
Dallas 8
Denver 8
Groningen 8
Houston 8
Istanbul 8
Jacksonville 8
Tijuana 8
Turku 8
Atlanta 7
Columbus 7
Hefei 7
Mumbai 7
Orem 7
Rio de Janeiro 7
Stockholm 7
Toronto 7
Collazzone 6
Des Moines 6
Glasgow 6
Incheon 6
Trinity 6
Dong Ket 5
Lappeenranta 5
Salvador 5
San Francisco 5
Turin 5
Vicenza 5
Woodbridge 5
Ankara 4
Baghdad 4
Belo Horizonte 4
Chennai 4
Da Nang 4
Dumaguete 4
Fremont 4
Guarulhos 4
Jinju 4
Konya 4
Kunming 4
Manchester 4
Olomouc 4
Ottawa 4
Paris 4
Querétaro 4
Shanghai 4
Totale 2.825
Nome #
Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice 155
Histological muscle characterization in hypertrophied Marchigiana cattle breed 143
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 136
RAGE in the pathophysiology of skeletal muscle. 126
Generation of an mdx/Ager–/– double mutant mouse. Preliminary data on skeletal muscle architecture. 124
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 121
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 121
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 121
S100B protein regulates myoblast and macrophage functions in skeletal muscle regeneration 118
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 112
Equisetum arvense standardized extract hinders age-related sarcopenia 110
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 109
Natural products to counteract muscle atrophy 109
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 106
Pharmacological targeting of the receptor for advanced glycation end-products (RAGE) to counteract cancer cachexia 103
Sertoli cell-secreted factors have promyogenic and antifibrotic properties on human DMD myoblasts with different mutations. 103
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 102
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 100
Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data 97
Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice 93
Transplantation of microencapsulated Sertoli cells: a new potential antiinflammatory approach to Duchenne muscular dystrophy (DMD). 90
Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast Muscle Atrophy and Sarcopenia 90
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 87
Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy 87
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? 87
The receptor RAGE: a potential molecular target in cancer cachexia 86
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 86
Mdx/Ager–/– mice show reduced muscle necrosis and inflammation compared with mdx mice 83
Transplantation of microencapsulated Sertoli cells in mdx mice reduces muscle inflammation and promotes muscle regeneration 82
Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness 81
The effects of microgravity on human skeletal muscle regeneration. 81
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 80
Use of Sertoli cells to treat DMD patients is supported by their immunomodulatory rather than immunosuppressive effect 79
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 78
S100 proteins in obesity: liaisons dangereuses 76
HEREGULIN-INDUCED UTROPHIN UPREGULATION PROMOTES RECOVERY OF MUSCLE HOMEOSTASIS IN MDX MICE TRANSPLANTED WITH MICROENAPSULATED SERTOLI CELLS 75
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 75
Ablation of RAGE (receptor for advanced glycation end-products) translates into reduced tumorigenic and cachectic potential in LLC-tumor bearing mice 74
Reductive stress in striated muscle cells 74
Transplantation of microencapsulated Sertoli cells in a mouse model of Duchenne muscular dystrophy (DMD) reduces inflammation and rescues muscle performance. 72
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 70
Novel data support the use of microencapsulated Sertoli cells as a potential treatment of DMD patients. 69
Self-powered temperature sensors harnessing membrane potential of living cells 62
Sertoli cells induce utrophin expression in human DMD myotubes with different mutations and exert promyogenic and antifibrotic effects 61
RAGE expression in rhabdomyosarcoma cells modulates metastasis formation in vivo. 61
Intraperitoneal transplantation of microencapsulated Sertoli cells counteracts muscle inflammation and rescues muscle performance in mdx mice. 60
The novel DMD experimental model, mdx/Ager–/– mouse reveals a role of RAGE in inflammatory processes in dystrophic muscles. 60
Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives 54
Beneficial effects of horsetail (Equisetum arvense) in in vitro models of sarcopenia and osteoporosis 52
Sertoli cells improve myogenic differentiation, reduce fibrogenic markers, and induce utrophin expression in human dmd myoblasts 48
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 46
Sertoli cells have promyogenic and antifibrotic effects, and induce utrophin expression in human DMD myotubes with different mutations in a heregulin β1/ErbB2/ERK1/2-dependent manner 39
The MyoGravity project to study real microgravity effects on human muscle precursor cells and tissue 37
Preparation of Human Muscle Precursor Cells for the MyoGravity Project - Cell Culture in Experiment Units for Space Flight Purpose 37
Totale 4.688
Categoria #
all - tutte 20.251
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.251


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021115 0 0 0 0 0 31 34 4 21 11 7 7
2021/2022420 4 65 9 19 12 12 12 106 12 39 58 72
2022/2023717 43 128 5 64 60 77 1 34 269 2 27 7
2023/2024387 18 28 9 35 18 12 102 8 19 24 37 77
2024/20251.448 46 103 148 84 166 68 136 153 195 87 186 76
2025/20261.068 140 116 96 276 308 132 0 0 0 0 0 0
Totale 4.688